Clinical Trials Directory

Trials / Completed

CompletedNCT01426373

Open-Label Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area

Multicenter, Open-label Study of ATX-101 (Sodium Deoxycholate Injection) for the Reduction of Localized Subcutaneous Fat in the Submental Area

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
165 (actual)
Sponsor
Kythera Biopharmaceuticals · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

To evaluate the safety of deoxycholic acid subcutaneous injections in the submental area (below the chin).

Conditions

Interventions

TypeNameDescription
DRUGDeoxycholic acid injectionFormulated as an injectable solution containing deoxycholic acid at a concentration of 10 mg/mL.

Timeline

Start date
2011-08-01
Primary completion
2013-06-01
Completion
2013-06-01
First posted
2011-08-31
Last updated
2016-01-14
Results posted
2016-01-14

Locations

18 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01426373. Inclusion in this directory is not an endorsement.